Wave Life Sciences (WVE) said in a regulatory filing that it considers its direct exposure to SVB’s (SIVB) receivership as immaterial, given that the aggregate amount of the company’s cash and restricted cash held at SVB is approximately $1.5M, which is $1.25M in excess of the FDIC-insured amount of $250,000.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on WVE: